🇺🇸 LGND — Ligand Pharmaceuticals Incorporated

Salud Compra fuerte
← Volver

Precio actual

306,20 USD

Máx. histórico

322,75

7 días

Split 1603:1000 del 02/11/2022

Caída desde máximo

-5,13%

Rango 52 semanas

175,89 – 326,63

Variación hoy

+2,41%

Cierre anterior

299,00

Rango de hoy

297,84 – 308,26

Volumen hoy

130.173

Peor caída histórica

-93,34%

06/03/2000 → 19/11/2008

Recuperado en 2694 días

Volatilidad anualizada ⓘ

59,76%

Información
Nombre completo
Ligand Pharmaceuticals Incorporated
Divisa
USD
Mercado
NasdaqGM
Sector
Salud
Industria
Biotechnology
Empleados
47
PER ⓘ
122,97 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
351,33 USD (puede no estar actualizado)
Primera cotización
18/11/1992
Precio actualizado
hace 17 horas
Sobre la empresa

Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.

Dividendos repartidos Total últimos 12 meses: 0,0000 USD · Yield: 0,00%
Fecha de pago Importe por participación
03/04/2007 9,3575 USD
Splits Registrados en el histórico de precios
Fecha Ratio
02/11/2022 1603:1000
19/11/2010 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
27/06/2000 48,42 49,59 46,55 47,02 -3,83% 6,28% 42.426
26/06/2000 47,02 48,89 45,85 48,89 +5,03% 6,47% 36.468
23/06/2000 46,79 48,19 45,15 46,55 +2,05% 6,50% 52.846
22/06/2000 49,71 50,53 45,38 45,62 -7,58% 10,35% 130.965
21/06/2000 51,47 51,47 48,66 49,36 +1,44% 5,45% 111.489
20/06/2000 49,13 51,23 48,42 48,66 -1,42% 5,71% 101.657
19/06/2000 50,06 50,30 47,72 49,36 -1,40% 5,14% 65.589
16/06/2000 49,36 50,06 48,19 50,06 +3,38% 3,79% 54.903
15/06/2000 47,26 48,60 46,79 48,42 +2,48% 3,84% 37.804
14/06/2000 50,06 51,47 46,79 47,26 +0,00% 9,35% 91.798
13/06/2000 50,53 50,53 46,32 47,26 +9,78% 8,33% 178.601
12/06/2000 48,42 50,53 42,58 43,04 -12,80% 16,43% 80.337
09/06/2000 44,45 49,59 43,75 49,36 +13,44% 13,16% 57.681
08/06/2000 46,67 46,79 43,51 43,51 -7,00% 7,02% 37.296
07/06/2000 44,92 46,79 43,75 46,79 +3,63% 6,77% 69.517
06/06/2000 43,98 48,19 41,64 45,15 +1,05% 14,89% 142.694
05/06/2000 43,04 44,68 40,70 44,68 +7,91% 9,24% 89.474
02/06/2000 41,64 44,68 41,17 41,41 +2,91% 8,43% 118.969
01/06/2000 41,17 41,17 37,43 40,24 +0,58% 9,09% 78.627
31/05/2000 40,24 41,64 37,90 40,00 +0,59% 9,30% 71.921
30/05/2000 37,43 39,77 36,26 39,77 +7,94% 9,38% 80.417
26/05/2000 40,70 40,70 36,85 36,85 -7,35% 9,48% 74.032
25/05/2000 43,40 43,98 39,54 39,77 +0,00% 10,24% 75.528
24/05/2000 43,28 43,28 37,20 39,77 -8,60% 14,05% 123.591
23/05/2000 44,56 46,09 43,51 43,51 -1,06% 5,77% 49.185
22/05/2000 47,72 48,19 43,98 43,98 -6,47% 8,82% 61.181
19/05/2000 47,72 48,19 46,09 47,02 -1,95% 4,41% 28.240
18/05/2000 47,02 48,66 46,55 47,96 +2,50% 4,48% 35.426
17/05/2000 47,26 48,89 46,32 46,79 -4,31% 5,45% 51.296
16/05/2000 46,79 50,30 46,32 48,89 +4,50% 8,50% 68.368